Introduction {#Sec1}
============

Tetramethylpyrazine (TMP), is a heterocyclic compound that contains nitrogen and has a taste similar to roasted nuts^[@CR1],[@CR2]^, leading to its common use for flavor in a lot of Chinese white liquors^[@CR3]^. It is also a central part of Ligusticum chuanxiong Hort, and it is always employed as a means of treating some diseases, such as cardiovascular and cerebrovascular^[@CR4]^. Pharmacological studies have demonstrated the ability of TMP to inhibit platelet aggregation, mediate vasodilation, and enhance coronary blood flow. Besides, this compound is widely employed as a flavor additive in the culinary industry^[@CR5],[@CR6]^, and also used as a standard compound in many other industries^[@CR7]^.

TMP can be generated via chemical or biological synthesis^[@CR8],[@CR9]^. Two major substrates forming pyrazines in the Maillard Model Systems are alanine and glycine. N-terminal amino acids represent both a source of nitrogen and can male up alkyl side chains in certain alkylpyrazines^[@CR8],[@CR10].^*Kosuge et al*.^[@CR11]^ found that microbes were capable of producing pyrazine in their study of *Bacillus subtilis*. The TMP that can be detected within Chinese white liquor has similarly been shown to be of primarily microbial origin rather than from the Maillard reaction^[@CR12]^. TMP is now hypothesized to be produced via a mechanism dependent upon the dynamic coupling of enzyme/thermal catalysis during solid-stage fermentation in Chinese liquor^[@CR13]^. *[Bacillus sp]{.ul}.* are capable of yielding high quantities of TMP when using acetoin as a precursor in an endogenous precursor screening strategy^[@CR9]^. Such microbial fermentation can produce TMP in a more cost-effective and environmentally friendly manner than more traditional enzymatic production strategies^[@CR14]^.

To our knowledge, the precursor of diacetyl is α-acetolactate. The α-acetolactate decarboxylase gene (*aldC*) can convert α-acetolactate to acetoin. Acetoin is the precursor of TMP, and acetoin can be converted with 2,3-butanediol (2,3-BD) each other. *B. lincheniformis* can commendably produce the TMP after gene modification. Through strengthening the degradation process and blocking the competing pathways, the carbon flux can flow to acetoin biosynthesis pathway. The acetoin then was accumulated to bolster TMP production. Glucose-derived TMP yields were higher for engineered strains relative to the initial controls. We additionally explored a novel means of adding supplemental acetaldehyde during fermentation, thereby enhancing TMP yields while keeping the overall cost low.

Materials and Methods {#Sec2}
=====================

Cells and reagents {#Sec3}
------------------

The strains, plasmids and their relevant genotypes for this study are compiled in Table [1](#Tab1){ref-type="table"}. Table [2](#Tab2){ref-type="table"} lists all the PCR primers in this study. All DNA manipulation was conducted via standard approaches. *Escherichia coli* was cultured at 37 °C with LB medium (10 g/L NaCl, 10 g/L tryptone, 5 g/L yeast extract) plus ampicillin (100 μg/mL) for transformant selection. During acetoin and TMP fermentation, 70 g/L glucose was supplemented into the LB broth, and every 12 hours we added 5 mL of the supplement (1 mg/mL glucose). In addition, LB plates containing 100 μg/mL filter-sterilized Ampicillin antibiotic were employed for *B. lincheniformis* transformant selection of Amp resistant strains. Solid medium was prepared via the addition of 20 g/L agar.Table 1Bacterial strains and plasmids used in this study.Strains/plasmidsRelevant characteristicsSource or reference**Strains***E. coli* DH5αHost strain in gene cloning/General cloning and storage of plasmidsLaboratory stock*B. licheniformis* BL1For production of TMPLaboratory stock*B. licheniformis* BLSThe mutant derived from *B. licheniformis* BL1Laboratory stock*B. licheniformis* BLCThe mutant derived from *B. licheniformis* BL1Laboratory stock*B. licheniformis* BLCSThe mutant derived from *B. licheniformis* BLCLaboratory stock**PlasmidsThis study**PMA5For construction of the gene-over expressed vectorLaboratory stockPMA5-*alsS*For *alsS*-over expressedThis studyPMA5-al*dC*For *aldC*-over expressedLaboratory stockPMA5-al*dC*-*alsS*For *aldC*-*alsS*-over expressedLaboratory stockTable 2Primers used in this study.PrimerSequence (5′→3′)Digestion site*alsS*-F1cctaaaaaggagcgattt[acatatg]{.ul}ATGAATAATGTAGCCGTA*Nde*I*alsS*-R2gctagcttgagctcgactctaga[ggatcc]{.ul}AGTTCTAACGAATCTCCG*Bam*HI*aldC*-F1ggatcctctagagtcgagctcaa[gctagc]{.ul}ATGAAAAGTGCAAGCAA*Bmt*I*aldC*-R2gaatttcgacctctaga[acgcgt]{.ul}AATGAGCCCTAACGGAA*Mlu*I

Recombinant strain production {#Sec4}
-----------------------------

The oligonucleotides listed in Table [2](#Tab2){ref-type="table"} were used to construct plasmids (Fig. [1](#Fig1){ref-type="fig"}) as a means of preparing a genome integration cassette. First, *B. lincheniformis* BL1 gDNA was used for the amplification of a 1739 bp CDS region of aldC and a 2462 bp CDS region of alsS using the aldC-F1/aldC-R2 and alsS-F1/alsS-R2 primer pairs, respectively. The PCR products were digested with *Eco*RV/ *Eco*RI and *Bsr*GI/ *Nco*I, respectively, and then inserted into PMA5.1 to construct the PMA5.1-aldC plasmid (Fig. [1a](#Fig1){ref-type="fig"}) and the PMA5.1-alsS plasmid (Fig. [1b](#Fig1){ref-type="fig"}), respectively. Finally, the CDS region of aldC and the CDS region of alsS were cloned into the plasmid PMA5.1 to construct the PMA5.1-aldC-alsS plasmid. The restriction sites were *Eco*RV/ *Eco*RI and *Bsr*GI/ *Nco*I (Fig. [1c](#Fig1){ref-type="fig"}).Figure 1Construction of plasmid PMA5-aldC, PMA5-alsS, and PMA5-aldC-alsS. The different plasmids are depicted as (**a--c**).

Production comparation of TMP production by different bacteria strains {#Sec5}
----------------------------------------------------------------------

We selected an individual *B. lincheniformis* BL1 colony that was then added to 5 mL LB with the corresponding antibiotic used for selection. Bacteria were cultured for 12 h at 37 °C and 200 rpm, then 2% (v/v) of this mixture was collected and combined for 12 h in a 250 mL flask with 50 mL LB containing 10 g/L glucose. For fermentation, a 4% (v/v) inoculum was incubated with this culture at a starting optical density (OD~600~) of 0.05 with the following parameters: a 500 mL flask containing 200 mL of LB and 70 g/L glucose was steadily mixed over 8 days at 200 rpm, and every 12 h a 5 mL volume of the glucose supplement (1 mg/mL) was added. The pH was maintained at 7.5 using 10 M NaOH solution.

Analytical methods {#Sec6}
------------------

Fermentation broth biomass and OD~600~ were measured via spectrophotometer (UV-722, Shanghai Xinmao Instrument Company Limited, China) at appropriate time points. An enzymatic membrane biosensor (SBA-40C, Institute of Biology, Shandong Academy of Sciences, China) with a glucose oxidase-immobilized membrane was utilized for the measurement of glucose levels in the fermentation broth. TMP levels were established via the headspace solid-phase microextraction and gas chromatography-nitrogen, as in past studies^[@CR5],[@CR15]^. Acetoin and 2,3-butanediol (2,3-BD) levels were measured by gas chromatography^[@CR16],[@CR17]^.

Statistical analysis {#Sec7}
--------------------

Experiment datas were accompanied by the number of experiments independently performed and expressed as mean ± SD. The differences of the acetaldehyde supplementation and the transformants, were confirmed by the Student's *t* test when compared with the parental strain. Differences at *P* \< 0.05 were considered to be significant differences in statistics.

Results {#Sec8}
=======

Characterization of the *aldC*/*alsS* over-expressed transformants {#Sec9}
------------------------------------------------------------------

In this study, the acetoin and acetolactate synthesis pathway was strengthened by over-expression of α-acetolactate decarboxylase gene (aldC) and α-acetolactate synthase gene (alsS), respectively. Acetoin, a tetramethylpyrazine (TMP) precursor (Fig. [2](#Fig2){ref-type="fig"}), accumulates and bolsters TMP yields. Relative to the acetoin yield of the initial strain (*Bacillus lincheniformis* BL1), that of the *aldC* and *alsS* overexpressed mutant strains (*B. lincheniformis* BLC and *B. lincheniformis* BLS) increased by 23.06% (w/w) from 15.22 g/L to 18.73 g/L and 6.77% (w/w) from 15.22 g/L to 16.25 g/L, respectively. Maximal TMP yield also rose by 15.47% (w/w) from 37.89 g/L to 43.75 g/L and 2.27% (w/w) from 37.89 g/L to 38.75 g/L in the *B. lincheniformis* BLC and *B. lincheniformis* BLS, respectively. However, 2,3-BD production fell by 6.73% (w/w) in the *aldC* overexpressed mutant (*B. lincheniformis* BLC) and increased by 14.62% (w/w) in the *alsS* overexpressed mutant (*B. lincheniformis* BLS) (Fig. [3](#Fig3){ref-type="fig"}).Figure 2Tetramethylpyrazine (TMP) biosynthetic pathway and other overflow metabolism pathways in *B. lincheniformis* BL1. *AlsS*, *ALDC*, and *bdhA* encode acetolactate synthase, acetolactate decarboxylase, and 2,3-butanediol (2,3-BD) dehydrogenase, respectively. PPP, pentose phosphate pathway; TCA, tricarboxylic acid cycle; NOD, Oxidative decarboxylation of non-enzymatic catalysis.Figure 3Production levels in wild-type and mutant strains. Data are average of three independent experiments and error bars represent ± SD. The maximum acetoin (gray bar), 2,3-BD (black bar), and TMP (blank bar) concentrations of BL1, BLC, BLS, BLCS, and acetaldehyde-regulated BL1 (BL1R1) cultivated with 200 ml LB in 500 ml flask shaken at 200 rpm and 37 °C for 144 h, 72(96) h, and 168 h. Data were confirmed by Student's *t* test (^a^*P* \< 0.05, n = 3).

Characterization of the *aldC-alsS* overexpressed recombinant strain {#Sec10}
--------------------------------------------------------------------

Compared with the acetoin and TMP yields of the *aldC* overexpressed mutant strain (*B. lincheniformis* BLC), the acetoin and TMP yields of the *aldC-alsS* overexpressed mutant strain (*B. lincheniformis* BLCS) decreased by 4.9% (w/w) from 18.73 g/L to 17.81 g/L and 3.43% (w/w) from 43.75 g/L to 42.25 g/L, respectively. In contrast, the yield of 2,3-BD rose by 23.2% (w/w) in the *aldC-alsS* overexpressed mutant strain (*B. lincheniformis* BLCS) (Fig. [3](#Fig3){ref-type="fig"}).

Effect of acetaldehyde supplementation in the fermentation process {#Sec11}
------------------------------------------------------------------

The effect of supplemented acetaldehyde on TMP and acetoin production in BL1 fermentation process was explored via the addition of 1, 2, 4, and 8 g/L acetaldehyde in the medium. Acetaldehyde supplementation of BL1 media improved TMP yields, with the addition of 1 g/L to 2 g/L of supplemental acetaldehyde impacting cell growth (Table [3](#Tab3){ref-type="table"}), TMP and acetoin, the concentration of residual glucose, and the yield of 2,3-BD (Fig. [4](#Fig4){ref-type="fig"}). The yield of TMP will increase with the increase of the dosage of acetaldehyde up to a dose of 2.0 g/L acetaldehyde, after which TMP levels do not rise further (Table [3](#Tab3){ref-type="table"}). Relative to unsupplemented BL1 (no dosage), the maximal TMP and acetoin yield rose by 13.83% (w/w) and 22.27% (w/w), respectively, in BL1R1 (BL1 with 1 g/L acetaldehyde). These increases were detected following 144 h and 168 h of culture, respectively (Fig. [3](#Fig3){ref-type="fig"}). These results suggest that a 1 g/L initial acetaldehyde concentration is ideal for maximizing the yield of TMP and acetoin in BL1.Table 3Effect of acetaldehyde addition on TMP production by *B. lincheniformis* BL1 (n = 3).Cultivation conditionsTime^a^ (h)Yield of Acetoin (g·L^−1^)Time^b^ (h)Yield of TMP (g·L^−1^)OD~600~^max^Initial glucose concentration (g·L^−1^)pHT^c^ (°C)acetaldehyde addition (g·L^−1^)70.07.5370120.115.22 ± 0.24168.537.89 ± 0.4044.78 ± 0.87**1.0144.118.61** ± **0.75**^**d**^**168.843.13** ± **0.58**^**d**^**38.72** ± **0.92**^**d**^2.0144.815.25 ± 0.63168.738.05 ± 0.6630.62 ± 0.45^d^4.0168.69.36 ± 0.41^d^192.627.69 ± 0.34^d^20.36 ± 0.33^d^8.0192.82.41 ± 0.07^d^192.83.87 ± 0.12^d^0.85 ± 0.02^da^Time in hours from inoculation to the maximal Acetoin concentration arrived.^b^Time in hours from inoculation to the maximal TMP concentration arrived.^c^T, temperature.^d^Values of the effect of acetaldehyde addition on production are significantly (Student's t test, *P* \< 0.05, n = 3) different from the parental strain BL1.Data are average values and standard deviations of triplicate experiments.Figure 4Effect of acetaldehyde addition on cell growth (●), 2,3-BD production (▲), and residual glucose concentration (■) by *B. lincheniformis* BL1. Data are average of three independent experiments and error bars represent ± SD. Product profiles of BL1 (open) and BL1R1 (filled symbols) are shown.

Effect of the acetaldehyde supplemention on the fermentation process {#Sec12}
--------------------------------------------------------------------

By adding 1 g/L of acetaldehyde to the medium, the effect of acetaldehyde on TMP and acetoin generation by BLC was explored. The TMP and acetoin production were also impacted by acetaldehyde supplementation of the BLC fermentation medium (Fig. [5](#Fig5){ref-type="fig"}). Relative to unsupplemented BLC, maximal TMP and acetoin yields were improved from 43.75 g/L to 47.26 g/L (an increase of 8.1% (w/w) and from 18.73 g/L to 20.13 g/L (an increase of 7.5% (w/w) respectively in BLCR1 (BLC with 1 g/L acetaldehyde). When the two recombinant strains were grown for 144 h and 168 h, these increases were observed (Fig. [5](#Fig5){ref-type="fig"}). As such, 1 g/L is also an optimal starting acetaldehyde concentration for achieving maximal TMP and acetoin by recomibniant BLC strain. However, there was almost no change in the yield of 2,3-BD.Figure 5Effect of acetaldehyde addition on TMP production (□), Acetoin production (Δ) and 2,3-BD production (○) by B. lincheniformis BLCR1. Data are average of three independent experiments and error bars represent ± SD. Product profiles of BLC (open) and BLCR1 (filled symbols) are shown.

Discussion {#Sec13}
==========

When the recombinant strains were grown for 168 h and 120 h respectively, the yield of TMP and acetoin in recombinant BLC rose by 23.99% (w/w) and 28.98% (w/w) compared with *Bacillus lincheniformis* BL1. The yield of TMP and acetoin in recombinant BLS increased slightly at the same time periods (Fig. [3](#Fig3){ref-type="fig"}). Compared with *Bacillus lincheniformis* BLC, the yield of TMP and acetoin in *Bacillus lincheniformis* BLCS decreased slightly with 2,3-BD increased slightly (Fig. [3](#Fig3){ref-type="fig"}). This rise was primarily attributable to (i) a lack of de novo early stationary phase acetaldehyde production, and (ii) acetoin precursor accumulation during this same time period. When cultured for 72 h and 120 h, BL1 accumulated over 13.6 g/L of 2,3-BD and 15.2 g/L of acetoin, respectively. The aldC overexpressed mutant strain (BLC) accumulated less than 11.4 g/L 2,3-BD and 18.8 g/L acetoin when cultured for 72 h and 120 h, respectively, in media containing 0.96 g/L residual glucose. Although acetoin and 2,3-BD levels fell during the stationary phase (Fig. [6](#Fig6){ref-type="fig"}). A prior study has similarly found that there is a 2,3-BD degradation pathway in which acetoin functions as an intermediate^[@CR18]^. In contrast, the production of 2,3-BD in recombinant BLS was more substantial than those of BL1 and BLC (Fig. [3](#Fig3){ref-type="fig"}).Figure 6Characterization of the *aldC*-over expressed transformants. Data are average of three independent experiments and error bars represent ± SD. Effects of aldC-overexpression on acetoin, TMP, and 2,3-BD production during the stationary phase of cultivation with 200 ml LB in 500 ml flask shaken at 200 rpm and 37 °C for 8 day. Product profiles of BL1 (filled symbols) and BLC (open) are shown. Squares, triangles, and circles represent TMP, acetion, and 2,3-BD concentrations of the same strain, respectively.

After 120 h, acetoin levels in BL1 samples began to fall as a consequence of ongoing degradation (Fig. [6](#Fig6){ref-type="fig"}). Acetoin can serve as a carbon source or a TMP precursor for BL1^[@CR19]^. The concentration of acetoin was increased in BLC; resulting in a higher TMP concentration. However, BL1 can metabolize acetoin more rapidly than can BLC^[@CR20]^.

Interestingly, with the acetaldehyde concentration in BL1 media rose from 0 g/L to 1 g/L, TMP and acetoin yields similarly rose from 37.89 g/L to 44.77 g/L and from 15.22 g/L to 17.94 g/L, respectively. Thus, acetaldehyde can facilitate TMP and acetoin production in a dose-dependent fashion. A 1 g/L acetaldehyde concentration was sufficient to achieve maximal TMP and acetoin yields. Nevertheless, the mechanism that the improvement of acetoin with acetaldehyde supplementation is poorly understood. We have hypothesized from the existing acetoin cleavage pathway that degradation of acetoin in microbial cells occurs on two levels. The first is the reversible transformation between acetoin and 2,3-BD. Secondly, acetoin can be used to produce acetyl-CoA and acetaldehyde under the action of the acetoin dehydrogenase complex (Ao DH ES), and acetaldehyde can then be converted into acetic acid or ethanol. Thus, the acetoin dehydrogenase system can catalyze the conversion of acetoin to acetaldehyde, and 2,3-BD dehydrogenase or acetoin reductase likely catalyzes the conversion between 2,3-butanediol (2,3-BD) and acetoin^[@CR21]^. Therefore, in our study, the initial acetaldehyde may have a feedback inhibition effect on the catalytic conversion of acetoin into acetaldehyde, which raises the concentration of acetoin and 2,3-BD, and also enhances the ability to synthesize TMP (Fig. [4](#Fig4){ref-type="fig"}). Alternatively, the initial addition of acetaldehyde could have a feedback inhibition effect on the Ao DH ES, which affects the conversion of acetoin into acetaldehyde and results in the accumulation of acetoin production, enhancing the ability to synthesize TMP in turn. In addition, the initial acetaldehyde can enhance the metabolism of acetaldehyde to acetyl-CoA, which indirectly provides feedback inhibition of pyruvate to the acetyl-CoA metabolic branch, thereby enhancing the pyruvate to acetoin metabolic branch (Fig. [2](#Fig2){ref-type="fig"}). So, when the acetaldehyde was added into the medium, there was an accumulation of the precursor acetoin in BL1 or BLC and an increased yield of TMP (Figs. [5](#Fig5){ref-type="fig"} and [7](#Fig7){ref-type="fig"}). Acetaldehyde is less favorable for cell growth (Fig. [4](#Fig4){ref-type="fig"}). Enzymatic activity is most robust when high levels are carbohydrates are available, and they fall once these carbon sources are exhausted^[@CR22]^. Thus, the initial suppression of the acetoin dehydrogenase system by acetaldehyde can impede the synthesis of acetaldehyde when remaining glucose levels at the end of fermentation were minimal. There is further evidence suggesting that 2,3-BD can be utilized as a carbon source in order to produce acetoin in the context of low carbon availability^[@CR14]^. However, cell growth will be adversely affected, and the product synthesed also be inhibited (Table [3](#Tab3){ref-type="table"}) when the specific inhibitory concentration of acetaldehyde reached. The acetaldehyde inhibitory mechanisms is still unclear, suggesting that there may be certain differentially regulated enzymes that can be impacted by acetaldehyde and which are involved in metabolic or synthetic processes, or the transfer process could be induced by different enzymes. Further study of the inhibitory role of acetaldehyde is thus warranted.Figure 7Effect of acetaldehyde addition on Acetoin production (■) and TMP production (▲) by *B. lincheniformis* BL1. Data are average of three independent experiments and error bars represent ± SD. Product profiles of BL1 (open) and BL1R1 (filled symbols) are shown.

In summary, we constructed a recombinant BLC strain for producing then high tetramethylpyrazine (TMP). Altering acetoin biosynthetic pathway carbon flux can effectively improve TMP yields. The overexpression of α-acetolactate decarboxylase (*aldC*) enhanced the strength of pathways responsible for competition and acetoin catabolism, which during the early stationary phase resulted in precursor acetoin accumulation and impaired 2,3-BD production. In flask fermentation, Compared with BL1 strain, the yield of TMP and acetoin in BLC rose by 23.99% and 28.98%, respectively. The addition of different concentrations of acetaldehyde enhanced TMP and acetoin production by BL1. Using acetaldehyde to supplement the substrate used for fermentation represents a novel means of readily enhancing TMP and acetoin production. We found that maximal TMP and acetoin yields rose by 13.83% (w/w) and 22.27 (w/w), respectively, when the acetaldehyde concentration were raised from 0 to 1 g/L. The underlying mechanisms should be further investigated.
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